Antidote Health, a telehealth platform company targeting the U.S. market, laid off approximately a third of its workforce in October 2022. The company, which had around 60 employees prior to the cuts, reduced its Israeli R&D staff by half, leaving just 17 employees locally. This move was part of a broader effort to streamline operations and preserve cash amid financial market uncertainty. Antidote, which also employs about 100 doctors, continues to focus on its mission of providing accessible and affordable virtual health insurance to millions of uninsured Americans.